Skip to main content

Advertisement

Log in

Fatigue in cancer patients is not related to changes in oxyhaemoglobin dissociation

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

There is only a weak association between the degree of anaemia and severity of fatigue in cancer patients. It has been hypothesised that there may be functional changes in the erythrocytes or haemoglobin of cancer patients and that this may result in fatigue even in the presence of a “normal” or “low normal” haematocrit.

Purpose

The purpose of the study was to investigate the relationship between oxyhaemoglobin dissociation and fatigue in patients with cancer and to compare oxyhaemoglobin dissociation between cancer patients and healthy controls.

Patients and methods

A heterogeneous group of patients with cancer (n=22) and a control group of healthy subjects without cancer (n=28) were studied. Subjects completed a fatigue questionnaire [the Functional Assessment of Cancer Therapy Fatigue (FACT-F) scale] and provided 10 ml of blood for analysis. Specimens were analysed to determine the partial pressure of oxygen at which 50% haemoglobin saturation occurred (P50) and were also sent for routine haematological and biochemical analysis.

Results

No differences were found between the oxyhaemoglobin dissociation curves of patients with cancer and controls. There was no significant correlation between fatigue severity and P50 in either patients or controls.

Conclusion

There is no evidence to support the hypothesis that cancer-related fatigue is due to differences in oxyhaemoglobin dissociation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer fatigue forum. Ann Oncol 11(8):971–975

    CAS  PubMed  Google Scholar 

  2. Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10(5):389–398

    PubMed  Google Scholar 

  3. Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528–538

    PubMed  Google Scholar 

  4. Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, Jenkinson C, Grey-Amante P, Doll H, Wild D (2002) The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 86(8):1243–1249

    CAS  PubMed  Google Scholar 

  5. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B, for the Epoetin Alfa Study Group (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial [comment]. J Clin Oncol 19(11):2865–2874

    CAS  PubMed  Google Scholar 

  6. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15(3):1218–1234

    CAS  PubMed  Google Scholar 

  7. Demetri G, Kris M, Wade J, Degos L, Cella D (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumour type: results from a prospective community oncology study. J Clin Oncol 16(10):3412–3425

    CAS  PubMed  Google Scholar 

  8. Stone P, Richards M, A’Hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11(5):561–567

    CAS  PubMed  Google Scholar 

  9. Epstein CD, Henning RJ (1993) Oxygen transport variables in the identification and treatment of tissue hypoxia. Heart Lung 22(4):328–345; quiz 346-8

    CAS  PubMed  Google Scholar 

  10. Mercuriali F, Inghilleri G (2001) Treatment of anaemia in cancer patients: transfusion of rHuEPO. In: Marty M, Pecorelli S (eds) Fatigue and cancer: European school of oncology scientific updates. Elsevier, Amsterdam, pp 185–200

    Google Scholar 

  11. Bron D (2001) Biological basis of cancer-related anaemia. In: Marty M, Pecorelli S (eds) Fatigue and cancer: European school of oncology scientific updates. Elsevier, Amsterdam, pp 45–50

    Google Scholar 

  12. Cella D (1997) The functional assessment of cancer therapy-anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl 2):13–19

    CAS  Google Scholar 

  13. Tucker V (1967) Method for oxygen content and dissociation curves on microlitre blood samples. J Appl Physiol 23:410–414

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from Ortho-biotech UK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick C. Stone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stone, P.C., Abdul-Wahab, A., Gibson, J.S. et al. Fatigue in cancer patients is not related to changes in oxyhaemoglobin dissociation. Support Care Cancer 13, 854–858 (2005). https://doi.org/10.1007/s00520-005-0850-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-005-0850-3

Keywords

Navigation